Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/16/1999WO1999064550A1 Use of basic polycondensates as antimicrobial active substance
12/16/1999WO1999064547A1 Contaminant reduced marine oil
12/16/1999WO1999064469A1 FIXATION INHIBITORS FOR $i(HELICOBACTER PYLORI)
12/16/1999WO1999064442A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999WO1999064424A1 Therapeutic agents
12/16/1999WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999WO1999064422A1 Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999WO1999064421A1 Acetylcholine enhancers
12/16/1999WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999WO1999064419A1 Pyrrole derivatives, preparation method and pharmaceutical compositions containing same
12/16/1999WO1999064417A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999WO1999064416A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999WO1999064415A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/16/1999WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999WO1999064413A1 Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents
12/16/1999WO1999064412A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
12/16/1999WO1999064411A1 Tetrahydroquinoline derivatives as glycine antagonists
12/16/1999WO1999064410A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
12/16/1999WO1999064409A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
12/16/1999WO1999064406A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999WO1999064405A1 Crystalline efavirenz
12/16/1999WO1999064403A1 1,5-benzodiazepine derivatives
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064400A1 INHIBITORS OF p38
12/16/1999WO1999064399A1 Protease inhibitors
12/16/1999WO1999064398A1 Quarternary ammonium compounds as anti-tussive agents
12/16/1999WO1999064395A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/16/1999WO1999064394A1 Neuropeptide y5 receptor antagonists
12/16/1999WO1999064393A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999WO1999064390A1 Phenylalanine derivatives as integrin inhibitors
12/16/1999WO1999064389A1 Inhibitors of the anandamide transporter as analgesic agents
12/16/1999WO1999064388A1 Hyperforin derivatives, the use thereof and formulations containing them
12/16/1999WO1999064071A1 A method for preparing a carbonized resin dna immunoadsorbent
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064046A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064028A1 Protecting neurons from ischemia
12/16/1999WO1999064027A1 Extracts of hypericum perforatum and formulations containing them
12/16/1999WO1999064019A1 Platinum complexes with anti-viral activity and method of using same
12/16/1999WO1999064018A1 Combination of compounds containing selenium and cytostatic agents
12/16/1999WO1999064016A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
12/16/1999WO1999064015A1 Pharmaceutical compositions containing alpha-tocopherylphosphocholine
12/16/1999WO1999064014A1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
12/16/1999WO1999064013A1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
12/16/1999WO1999064012A1 Altering sex ratio of offspring in mammals
12/16/1999WO1999064011A1 Drugs
12/16/1999WO1999064010A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999WO1999064009A1 Use of an nk-1 receptor antagonist for treating cognitive disorders
12/16/1999WO1999064008A1 Use of a nk-1 receptor antagonist for treating sexual dysfunctions
12/16/1999WO1999064007A1 Use of a nk-1 receptor antagonist for treating bipolar disorders
12/16/1999WO1999064006A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999WO1999064005A1 Use of molecules that modulate an energy related associated state
12/16/1999WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE
12/16/1999WO1999064003A1 Method of treatment of patients with initial liver cancer
12/16/1999WO1999064002A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999WO1999064001A2 Methods and compositions for increasing penetration of hiv protease inhibitors
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063992A1 Novel calcium channel drugs and uses
12/16/1999WO1999063990A1 New use
12/16/1999WO1999063989A1 Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063987A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
12/16/1999WO1999063986A1 Formulations for the treatment of gastro-oesophageal reflux
12/16/1999WO1999063985A1 Compositions and methods for treatment of cough
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063982A1 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
12/16/1999WO1999063981A2 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999WO1999063980A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
12/16/1999WO1999063979A2 Inhibition of δ-9-desaturase activity by saponins
12/16/1999WO1999063978A2 Methods of treating microbial infection and therapeutic formulations therefor
12/16/1999WO1999063977A2 Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders
12/16/1999WO1999063976A2 Liver-selective glucocorticoid antagonist for treating diabetes
12/16/1999WO1999063975A2 A method for stimulating the immune system
12/16/1999WO1999063974A2 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
1 ... 6393 6394 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 ... 7860